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Abstract
The 2015 International Conference on Intelligent Biology and Medicine (ICIBM 2015) was held on November 13–15,
2015 in Indianapolis, Indiana, USA. ICIBM 2015 included eight scientific sessions, three tutorial sessions, one poster
session, and four keynote presentations that covered the frontier research in broad areas related to bioinformatics,
systems biology, big data science, biomedical informatics, pharmacogenomics, and intelligent computing. Here, we
present a summary of the 10 research articles that were selected from ICIBM 2015 and included in the supplement
to BMC Systems Biology.
Introduction
Since its inception in 2012, the International Conference
on Intelligent Biology and Medicine (ICIBM) has hosted
a variety of interdisciplinary educational events, includ-
ing keynote lectures from world-renowned experts in
bioinformatics, genomics, computational biology, bio-
engineering, and intelligent computing fields, educa-
tional and engaging tutorial and workshop sessions,
poster presentations and discussions, and innovative re-
search presentations in emerging areas like data science.
ICIBM aims to provide a venue to promote interactions
of trainees and junior scientists with established scien-
tists and engineers so that their career can be developed
at the right direction. ICIBM 2015, which was held on
November 13–15, 2015 in Indianapolis, Indiana, USA,
gained success again for promoting both education and
research exchange. Specific conference program is de-
scribed in our editorial to ICIBM supplemental issue to
BMC Genomics [1]. Here, we briefly introduce the 10
research articles collected in this supplement to BMC
Systems Biology. These articles covered research areas in
machine learning approaches, models for big data, com-
plex disease and drug prediction, drug-drug interactions
and cellular networks, Boolean networks and computa-
tional tool for network analysis, among others. Each
manuscript was reviewed by three or more reviewers
and went through two rounds of reviews.
The first paper is to apply machine-learning approach
to classify breast cancer patients. Breast cancer is a
highly heterogeneous disease that is difficult to devise
effective therapeutic strategies. In this study, Vural et al.
uniquely used only somatic mutation profile data to
identify and predict breast cancer subgroups [2]. The
authors demonstrated that gene mutation profiles could
be effectively used in unsupervised machine-learning
methods to identify clinically distinguishable breast cancer
subgroups. By using non-negative matrix factorization
method, the authors identified three clinically distinct
breast cancer groups. Furthermore, they developed a
supervised classification model to predict the stage of the
patients.
In the second paper, Xu and Wang developed a com-
putational approach to characterize which and how
human gut microbial metabolites may contribute to
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various aspects of Alzheimer’s disease (AD), a disease
that is currently under extensive investigation [3]. They
found metabolites were significantly associated with vari-
ous aspects of AD, such as AD susceptibility, cognitive
decline, biomarkers, age of onset, and the onset of AD,
which provided evidence to support that human gut
microbial metabolites might serve as an important
mechanistic link between environmental exposure and
AD symptoms. Furthermore, their pathway analysis
revealed metabolite trimethylamine N-oxide (TMAO),
a gut microbial metabolite of dietary meat and fat,
providing insights into the mechanisms of dietary
meat and fat on AD.
In the next paper, Li et al. digitalized a novel ani-
mal model for acute myeloid leukemia, which
accounted for both leukemic and normal blood cells
in the disease [4]. Specifically, the authors modeled
multi-tissue hematopoietic dynamics in the leukemic
body. The authors demonstrated that their computa-
tional model was valid and accurate, and that the
functional depression of hematopoietic stem and pro-
genitor cells under leukemia could be inferred by
their model using the cell kinetics data as input only.
Accordingly, their modeling is potentially capable of
saving experimental costs, while effectively facilitating
knowledge acquisition.
Cheng et al. developed a network-based framework to
quantitatively examine cellular network heterogeneity
and modularity in cancer [5]. Specifically, they con-
structed gene co-expressed protein interaction networks
derived from large-scale RNA-Seq data across eight can-
cer types generated from The Cancer Genome Atlas
(TCGA) project. They performed gene network entropy
and balanced versus unbalanced motif analyses to inves-
tigate cellular network heterogeneity and modularity in
tumor versus normal tissues, different stages of progres-
sion, and drug resistant versus sensitive cancer cell lines.
The authors found that tumorigenesis could be charac-
terized by a significant increase of gene network entropy
in all of the eight cancer types examined. Furthermore,
they showed that network entropy could be used to
characterize tumor progression and anticancer drug re-
sponses. In addition, the authors provided potential
network-level evidence that smoking might increase can-
cer cellular network heterogeneity and further contribute
to tyrosine kinase inhibitor resistance. In summary, the
authors demonstrated that network properties such as
network entropy and unbalanced motifs associated with
tumor initiation, progression, and anticancer drug re-
sponses, suggesting new potential network-based prog-
nostic and predictive measure in cancer.
Predicting drug synergy using high-throughput expres-
sion profiles is an emerging topic in molecular cancer
therapeutics development. Through integrative analyses
of functional (modeled by gene sets) and gene-level data,
Hsu et al. demonstrated that the similarity in functions
or genes perturbed by two drugs was predictive of their
synergistic effects based on the novel prediction scores
measuring the synergy [6]. Assessed against a gold
standard dataset derived by the DREAM consortium, the
scores were shown to achieve better performance than
previous computational methods. The results in this
study are expected to facilitate the screening for putative
synergistic drug combinations and accelerate the
realization of precision cancer treatment.
Information about drug–drug interactions (DDIs) sup-
ported by scientific evidence is crucial for establishing
computational knowledge bases for applications like
pharmacovigilance. New reports of DDIs have been
rapidly accumulating in the scientific literature; thus,
text-mining techniques for automatic DDI extraction are
critical. Zhang et al. proposed a novel approach for auto-
mated pharmacokinetic (PK) DDI detection that incor-
porates syntactic and semantic information into graph
kernels, to address the problem of sparseness associated
with syntactic-structural approaches [7]. The authors
first developed a novel all-path graph kernel using shal-
low semantic representation of sentences. Then, they
statistically integrated fine-granular semantic classes into
the dependency and shallow semantic graphs. In the
evaluation on the PK DDI corpus, their approach signifi-
cantly outperformed the original all-path graph kernel,
which is based on dependency structure.
In the next paper, Du et al. introduced a novel sparse
canonical correlation analysis (SCCA) model using the
Graph OSCAR constraint [8]. The model was developed
for identifying bi-multivariate imaging genetic associa-
tions while encouraging highly correlated features to be
selected together. Because the model does not require
the pre-definition of the sign of the sample correlation,
it could reduce the estimation bias. Furthermore, it
could combine those highly correlated features together
regardless of whether they are positively or negatively
correlated. The authors showed that the performance of
the model would be promising based on both simulated
and real data, and they identified a strong relationship
between the APOE SNP rs429358 and the amyloid bur-
den measure in the frontal region.
We have witnessed numerous high-throughput “omics”
data generated during the past decade. While the data is
large, it is often complicated. The biomedical scientists
have been hindered from fully studying and uncovering
disease associated networks by the lack of efficient com-
putational tools. Wan et al. introduced an open source R
package to help learn the network structure from data
acquired from various high-throughput genomics tech-
nologies [9]. Their tool allows the data to be modeled
using the native distribution instead of normalizing the
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data to follow Gaussian distribution, as most other statis-
tical models require. In addition, the parallelization of
their algorithms provides an efficient tool for computing
large-scale networks.
Liu et al. explored controllability of a Boolean network
based on the transition matrix and time transition
diagram [10]. In their study, the authors determined the
necessary and sufficient condition for a controllable
Boolean network and mapped this requirement in transi-
tion matrix to real Boolean functions and structure
property of a network. They found six simplest forms of
controllable 2-node Boolean networks and explored the
consistency of transition matrices while extending these
six forms to controllable networks with more nodes.
Next, the authors proposed the first state feedback con-
trol strategy to drive the network based on the status of
all nodes in the network. In a case study, the authors
applied the reachability condition to the major switch of
P53 pathway to predict the progression of the pathway
and validate the prediction with published experimental
results. The control strategy reported in their paper
allows investigators to apply real time control to drive
Boolean networks, a feature having missed in the current
control strategy for Boolean networks.
In the last paper, Wu et al. applied an integrative gene
co-expression analysis approach to identify a novel,
three-transcription factor based prognostic signature
[11]. The signature could cluster the glioma into three
molecular subtypes with significantly different transcrip-
tomic patterns and clinical outcomes. The authors
explored the glioma molecular mechanisms at the tran-
scriptional regulation level. They suggested potential
drug targets for different glioma molecular subtypes.
This integrative approach is extendable to other cancer
studies for detecting biomarkers in both diagnosis and
pathogenesis.
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